血液分离市场报告：2031 年趋势、预测与竞争分析

全球血液白血病市场未来前景光明，血液中心和医院市场都存在巨大机会。预计到 2031 年全球白血球分离术市场规模将达到 25 亿美元，2025 年至 2031 年的复合年增长率为 7.5%。市场的主要驱动力是慢性肾臟病盛行率的上升、政府鼓励捐血的宣传活动增多以及对血液成分的需求不断增长。

• 根据Lucintel的预测，离心法广泛应用于製备新鲜冷冻血浆和浓缩红血球等血液成分，在预测期内，离心法仍将占据最大份额。
• 根据最终用途，血液中心在预测期内预计仍将占据较大的份额。
• 预计北美在整个预测期内仍将是最大的地区，这是由于该地区人口越来越多地采用先进的血液分离系统以及血液相关疾病的患病率不断上升。

血液分离市场的策略性成长机会

血液成分分析市场在各个关键应用领域提供了多种策略成长机会。这些机会是由技术进步和对有效治疗日益增长的需求所推动的。

• 肿瘤学应用：由于针对癌细胞的新型分离术已显示出良好的效果，因此肿瘤学应用具有巨大的成长潜力。血液分离技术在癌症治疗的应用正在不断扩大。
• 治疗自体免疫疾病：血液分离术越来越多地被应用于治疗自体免疫疾病，提供标靶治疗，从而改善患者的治疗效果。该应用是市场的一个主要成长领域。
• 扩展到新兴市场：由于医疗保健投资的增加和患者数量的增加，扩展到新兴市场，尤其是亚太市场，提供了巨大的成长机会。市场参与企业正致力于向这些地区扩张。
• 技术创新：对新型血液分离技术（如自动化系统和改进的过滤器）的投资，透过提高治疗效率和患者舒适度提供了成长机会。技术进步正在推动市场成长。
• 监管部门的核准和支持：获得新型血液分离设备和治疗方法的监管核准，有助于引入创新解决方案并扩大市场范围，从而提供成长机会。

这些策略性成长机会正在透过扩大治疗应用、拓宽市场范围和促进技术创新来推动血液白血病市场向前发展。企业正专注于这些领域以挖掘市场潜力。

血液分离市场驱动因素与挑战

血液白血球分离术市场受到各种驱动因素​​和挑战的影响，这些驱动因素和挑战决定了其成长。技术进步、监管因素和经济状况在市场动态中发挥关键作用。

血液成分分析市场受以下因素驱动：

• 技术进步：自动化系统和改进的过滤器等血液分离技术的创新正在提高治疗的准确性和效率，从而推动市场成长。
• 采用率不断提高：在癌症和自体免疫疾病等各种治疗应用中，采用血液分离技术的情况正在增加，从而增加了市场需求。
• 监管支援：监管部门对新型血液透析设备和治疗方法的核准和支持正在推动创新和产品引进，从而加速市场成长。
• 增加医疗保健投资：医疗保健基础设施投资的增加，尤其是在新兴市场，正在推动血液分离服务和技术的扩展。
• 扩大应用范围：血液白血球分离技术在各个医学学科中的应用日益广泛，为市场成长和创新创造了新的机会。

血液分离市场面临的挑战包括：

• 高成本：先进的血液分离技术和治疗的成本高昂，可能会限制其取得和采用，尤其是在发展中地区。
• 监管障碍：满足新型血液透析设备和治疗方法的复杂监管要求可能会延迟产品核准和市场进入。
• 製造的复杂性：血液透析设备和消耗品的製造很复杂，为扩大生产和维持品质带来了挑战。

血液白血球分离术市场受技术进步、日益普及和监管支援的推动，但面临高成本和监管障碍等挑战。克服成长动力和挑战对于市场的成功至关重要。

目录

第一章执行摘要

第动态章。

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球血液分离市场趋势（2019-2024 年）及预测（2025-2031 年）
• 全球血液透析市场按产品类型划分
  • 耗材和试剂
  • 软体
  • 装置
• 全球血液透析市场（依技术划分）
  • 离心
  • 膜分离
  • 选择性吸附
• 全球血液透析市场（按程序划分）
  • 捐赠者/自动血液分离术
  • 治疗性血液分离术
• 全球血液透析市场（按最终用途划分）
  • 血液中心
  • 医院
  • 其他的

第 4 章区域市场趋势与预测分析（2019-2031 年）

• 全球血液透析市场按区域划分
• 北美血液采集市场
• 欧洲血液透析市场
• 亚太地区血液采集市场
• 世界其他地区的血液成分分析市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球血液分离市场成长机会（依产品类型）
  • 全球血液分离市场按技术分類的成长机会
  • 全球血液分离市场成长机会（按程序划分）
  • 全球血液分离市场成长机会（依最终用途划分）
  • 全球血液分离市场各区域成长机会
• 全球血液分离市场的新趋势
• 战略分析
  • 新产品开发
  • 全球血液透析市场产能扩张
  • 全球血液分离市场中的企业合併
  • 认证和许可

第七章主要企业简介

• Kawasumi Laboratories
• Nikkiso
• Haemonetics Corporation
• Asahi Kasei Medical
• Cerus Corporation
• Kaneka Corporation
• Charles River Laboratories International
• B. Braun Melsungen
• Fresenius Kabi
• Terumo BCT

The future of the global apheresis market looks promising with opportunities in the blood center and hospital markets. The global apheresis market is expected to reach an estimated $2.5 billion by 2031 with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the rising prevalence of chronic renal diseases, increasing government campaigns encouraging blood donation, and expanding demand for blood components.

• Lucintel forecasts that, within the method category, the centrifugation segment will remain the largest segment over the forecast period due to its widespread adoption in the preparation of blood components, including fresh frozen plasma and packed red blood cells.
• Within the end use category, blood centers will remain a larger segment over the forecast period.
• In terms of region, North America will remain the largest region over the forecast period due to rising adoption of cutting-edge apheresis systems and growth in the incidence of blood-related illnesses among the population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Apheresis Market

The apheresis market is influenced by several emerging trends that are transforming the industry. These trends reflect advancements in technology and shifts in treatment approaches, shaping the future of apheresis therapies.

• Technological Advancements: Innovations in apheresis technology, such as automated systems and improved filters, are enhancing treatment precision and patient comfort. These advancements are driving growth by making apheresis more efficient and accessible.
• Expansion in Therapeutic Applications: Apheresis is increasingly used for a wider range of conditions, including autoimmune diseases, cancer, and genetic disorders. This expansion is broadening the market and increasing demand for specialized apheresis therapies.
• Growth in Emerging Markets: Emerging markets, particularly in Asia-Pacific, are experiencing rapid growth in apheresis due to rising healthcare investments and increasing patient populations. This trend is opening new opportunities for market players in these regions.
• Integration of Data Analytics: The use of data analytics and AI in apheresis procedures is improving treatment outcomes and operational efficiency. These technologies are enabling more personalized and effective apheresis treatments.
• Regulatory Support and Approvals: Increasing regulatory approvals and support for new apheresis devices and therapies are accelerating market growth. Governments and health authorities are facilitating the introduction of innovative apheresis solutions.

These trends are reshaping the apheresis market by driving technological advancements, expanding therapeutic applications, and opening new growth opportunities. The focus on innovation and regulatory support is enhancing the effectiveness and reach of apheresis therapies.

Recent Developments in the Apheresis Market

Key developments in the apheresis market reflect technological advancements, regulatory changes, and increasing adoption across various therapeutic areas. These developments are driving growth and expanding the scope of apheresis treatments globally.

• Advanced Apheresis Technologies: New automated apheresis systems with enhanced precision and efficiency have been introduced, improving patient outcomes and treatment consistency. These innovations are setting new standards in the market.
• Regulatory Approvals for New Devices: Recent regulatory approvals for advanced apheresis devices have facilitated market expansion. These approvals are enabling the introduction of new technologies and expanding the range of available apheresis treatments.
• Increased Adoption in Oncology: The use of apheresis in oncology has increased, with new therapies targeting cancer cells showing promising results. This growth reflects a broader application of apheresis in cancer treatment.
• Expansion in Emerging Markets: The apheresis market is expanding rapidly in emerging markets due to increasing healthcare infrastructure and investments. This growth is opening new opportunities for market players and driving global market expansion.
• Innovative Therapeutic Applications: New therapeutic applications of apheresis are being explored, including treatments for autoimmune diseases and genetic disorders. These innovations are broadening the market and increasing demand for apheresis therapies.

These developments are significantly impacting the apheresis market by driving technological advancements, regulatory approvals, and expanding therapeutic applications. The market is growing rapidly due to these innovations and increasing global demand.

Strategic Growth Opportunities for Apheresis Market

The apheresis market offers several strategic growth opportunities across key applications. These opportunities are driven by advancements in technology and increasing demand for effective treatments.

• Oncology Applications: There is significant growth potential in oncology applications, with new apheresis therapies targeting cancer cells showing promising results. This opportunity is expanding the use of apheresis in cancer treatment.
• Autoimmune Disease Treatments: Apheresis is increasingly used for treating autoimmune diseases, providing targeted therapies that improve patient outcomes. This application is a key growth area in the market.
• Emerging Markets Expansion: Expanding into emerging markets, particularly in Asia-Pacific, offers substantial growth opportunities due to rising healthcare investments and increasing patient populations. Market players are focusing on these regions for expansion.
• Technological Innovations: Investing in new apheresis technologies, such as automated systems and improved filters, presents growth opportunities by enhancing treatment efficiency and patient comfort. Technological advancements are driving market growth.
• Regulatory Approvals and Support: Gaining regulatory approvals for new apheresis devices and therapies opens up growth opportunities by facilitating the introduction of innovative solutions and expanding market reach.

These strategic growth opportunities are driving the apheresis market forward by expanding therapeutic applications, increasing market reach, and fostering innovation. Companies are focusing on these areas to capitalize on market potential.

Apheresis Market Driver and Challenges

The apheresis market is influenced by various drivers and challenges that shape its growth. Technological advancements, regulatory factors, and economic conditions play key roles in market dynamics.

The factors responsible for driving the apheresis market include:

• Technological Advancements: Innovations in apheresis technology, including automated systems and improved filters, are enhancing treatment precision and efficiency, driving market growth.
• Increased Adoption: Growing adoption of apheresis for various therapeutic applications, including oncology and autoimmune diseases, is expanding market demand.
• Regulatory Support: Regulatory approvals and support for new apheresis devices and therapies are accelerating market growth by facilitating innovation and product introductions.
• Rising Healthcare Investments: Increased investments in healthcare infrastructure, particularly in emerging markets, are driving the expansion of apheresis services and technologies.
• Expanding Applications: The broadening use of apheresis in diverse medical fields is creating new opportunities for market growth and innovation.

Challenges in the apheresis market are:

• High Costs: The high cost of advanced apheresis technologies and treatments can limit accessibility and adoption, particularly in developing regions.
• Regulatory Hurdles: Navigating complex regulatory requirements for new apheresis devices and therapies can delay product approvals and market entry.
• Manufacturing Complexity: The complexity of manufacturing apheresis equipment and supplies can pose challenges in scaling up production and maintaining quality.

The apheresis market is driven by technological advancements, increased adoption, and regulatory support, but faces challenges such as high costs and regulatory hurdles. Addressing these challenges while capitalizing on growth drivers is crucial for market success.

List of Apheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies apheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the apheresis companies profiled in this report include-

• Kawasumi Laboratories
• Nikkiso
• Haemonetics Corporation
• Asahi Kasei Medical
• Cerus Corporation
• Kaneka Corporation
• Charles River Laboratories International
• B. Braun Melsungen
• Fresenius Kabi
• Terumo BCT

Apheresis by Segment

The study includes a forecast for the global apheresis market by product type, method, procedure, end use, and region.

Apheresis Market by Product Type [Analysis by Value from 2019 to 2031]:

• Disposable and Reagents
• Software
• Devices

Apheresis Market by Method [Analysis by Value from 2019 to 2031]:

• Centrifugation
• Membrane Separation
• Selective Adsorption

Apheresis Market by Procedure [Analysis by Value from 2019 to 2031]:

• Donor/Automated Apheresis
• Therapeutic Apheresis

Apheresis Market by End Use [Analysis by Value from 2019 to 2031]:

• Blood Centers
• Hospitals
• Others

Apheresis Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Apheresis Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The below image highlights recent developments by major apheresis producers in key regions: the USA, China, India, Japan, and Germany

• United States: In the U.S., recent developments include the introduction of advanced apheresis technologies and increased adoption of automated systems. Regulatory approvals for new apheresis devices and therapies, particularly for oncology and autoimmune disorders, have accelerated market growth.
• China: China is witnessing significant growth in the apheresis market due to government initiatives supporting healthcare advancements. There is a rise in local manufacturing of apheresis equipment and an increase in clinical applications, particularly for treating blood disorders and cancer.
• Germany: Germany has seen advancements in apheresis technologies, with a focus on improving efficiency and patient comfort. The market is supported by strong healthcare infrastructure and research institutions developing new therapeutic applications for apheresis, especially in hematology and oncology.
• India: In India, the apheresis market is expanding due to increasing healthcare access and investments in medical technology. There is a growing focus on improving apheresis procedures for treating various diseases, supported by government health programs and private sector investments.
• Japan: The Japanese apheresis market is driven by technological innovations and a growing demand for advanced therapeutic solutions. The country is focusing on developing new apheresis technologies and expanding their use in treating chronic diseases and cancer.

Features of the Global Apheresis Market

Market Size Estimates: Apheresis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Apheresis market size by various segments, such as by product type, method, procedure, end use, and region in terms of value ($B).

Regional Analysis: Apheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, methods, procedures, end uses, and regions for the apheresis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the apheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the apheresis market by product type (disposable and reagents, software, and devices), method (centrifugation, membrane separation, and selective adsorption), procedure (donor/automated apheresis and therapeutic apheresis), end use (blood centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Apheresis Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Apheresis Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Apheresis Market by Product Type
  • 3.3.1: Disposable and Reagents
  • 3.3.2: Software
  • 3.3.3: Devices
• 3.4: Global Apheresis Market by Method
  • 3.4.1: Centrifugation
  • 3.4.2: Membrane Separation
  • 3.4.3: Selective Adsorption
• 3.5: Global Apheresis Market by Procedure
  • 3.5.1: Donor/Automated Apheresis
  • 3.5.2: Therapeutic Apheresis
• 3.6: Global Apheresis Market by End Use
  • 3.6.1: Blood Centers
  • 3.6.2: Hospitals
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Apheresis Market by Region
• 4.2: North American Apheresis Market
  • 4.2.1: North American Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.2.2: North American Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.3: European Apheresis Market
  • 4.3.1: European Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.3.2: European Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.4: APAC Apheresis Market
  • 4.4.1: APAC Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.4.2: APAC Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.5: ROW Apheresis Market
  • 4.5.1: ROW Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.5.2: ROW Apheresis Market by End Use: Blood Centers, Hospitals, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Apheresis Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Apheresis Market by Method
  • 6.1.3: Growth Opportunities for the Global Apheresis Market by Procedure
  • 6.1.4: Growth Opportunities for the Global Apheresis Market by End Use
  • 6.1.5: Growth Opportunities for the Global Apheresis Market by Region
• 6.2: Emerging Trends in the Global Apheresis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Apheresis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Apheresis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Kawasumi Laboratories
• 7.2: Nikkiso
• 7.3: Haemonetics Corporation
• 7.4: Asahi Kasei Medical
• 7.5: Cerus Corporation
• 7.6: Kaneka Corporation
• 7.7: Charles River Laboratories International
• 7.8: B. Braun Melsungen
• 7.9: Fresenius Kabi
• 7.10: Terumo BCT